The lack of significant variation in FGF10 expression in PPB patients, combined with the differences in RNA levels of the FGF10 pathway effectors ETV4, ETV5 and ELF5, raised questions about the role of FGF10 in PPB pathogenesis. This evidence concerns the gene ETV5 and pleuropulmonary blastoma.